Filing Details

Accession Number:
0001209191-21-017572
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-03 21:05:17
Reporting Period:
2021-03-01
Accepted Time:
2021-03-03 21:05:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1533040 Phio Pharmaceuticals Corp. PHIO Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1792987 L Robert Ferrara C/O Phio Pharmaceuticals Corp.
257 Simarano Drive, Suite 101
Marlborough MA 01752
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.0001 Par Value Acquisiton 2021-03-01 10,000 $0.00 12,318 No 4 A Direct
Common Stock, $0.0001 Par Value Acquisiton 2021-03-03 682 $3.15 13,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 P Direct
Footnotes
  1. Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date.
  2. Effective as of 12:01 a.m. Eastern Time on January 15, 2020, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-55.